Bluebird Bio

Developer of gene therapies for severe genetic and rare diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 1992 groups508 employees language bluebirdbio.com

Registered entities

Innovation

87 patent families (17 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 8,955 times.

YearFilings
201511
201612
201720
201831
201946
202051
202132
202222
20239
20247
20255
20264

Social engagement

Social engagement: 140.7K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include Third Rock Ventures, Easton Capital Investment Group, TVM Capital, Forbion.

Investor typeCountShare
Venture capital650%
Private equity217%
Accelerator & incubator18%
Other / undisclosed325%

Hiring activity

No recent openings observed

No roles tracked in the last 12 months

11 Sep 2025 · Director / Sr. Director, Quality Systems · Somerville

Based on job postings tracked across public sources.

Recent activity

18 Sep 2025
Expansion
Coming soon